Summer launch forecast for EU platform to co-ordinate early drug licensing pathways
This article was originally published in SRA
Executive Summary
A new platform under the EU's public-private Innovative Medicines Initiative to co-ordinate and support regulatory pathways that are being developed to speed up the evaluation of medicines within the current pharmaceutical legislation could be in place by summer1.